SCHEMBL9980544

SCHEMBL9980544

Cc1[nH]c(C2CCCN2C(=O)O)nc1I

nearest known ligand 0.41

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 16/20 0.40
▸ HCRTR2 O43614 16/20 0.40
▸ OPRD1 P41143 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18815239 0.86 OPRD1 (0.40) HCRTR1HCRTR2OPRD1
SCHEMBL18815238 0.86 OPRD1 (0.40) HCRTR1HCRTR2OPRD1
SCHEMBL13505317 0.86 HCRTR1 (0.37) HCRTR1HCRTR2
SCHEMBL1293417 0.86 HCRTR1 (0.37) HCRTR1HCRTR2
SCHEMBL1914149 0.83 HCRTR1 (0.38) HCRTR1HCRTR2
SCHEMBL15367045 0.83 ALDH1A1 (0.47) —
SCHEMBL12066763 0.83 ALDH1A1 (0.47) —
SCHEMBL9980505 0.80 PRCP (0.36) HCRTR1HCRTR2
SCHEMBL9980523 0.80 HCRTR1 (0.39) HCRTR1HCRTR2
SCHEMBL29136404 0.77 HCRTR1 (0.38) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2575475-A1 INHIBITORS OF HCV NS5A Presidio Pharmaceuticals, Inc. (US) 2013-04-10 — — EP disclosed
WO-2011150243-A1 INHIBITORS OF HCV NS5A PRESIDIO PHARMACEUTICALS, INC. (US) 2011-12-01 — — WO disclosed
Send feedback